This correlation has been explained by the recruitment of ERβ-expressing mast cells [122] and CD4+ T cells [123] in bladder cancer and by the association of mast and CD4+ T cells in the tumor microenvironment with enhanced invasiveness of bladder cancer cells. This evidence concerns the gene ESR2 and urinary bladder carcinoma.